144 related articles for article (PubMed ID: 11204951)
1. Prolidase-activated prodrug for cancer chemotherapy cytotoxic activity of proline analogue of chlorambucil in breast cancer MCF-7 cells.
Bielawska A; Bielawski K; Chrzanowski K; Wołczyński S
Farmaco; 2000; 55(11-12):736-41. PubMed ID: 11204951
[TBL] [Abstract][Full Text] [Related]
2. Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase.
Bielawska A; Chrzanowski K; Bielawski K; Pałka J
Pharmazie; 2001 Apr; 56(4):290-4. PubMed ID: 11338665
[TBL] [Abstract][Full Text] [Related]
3. Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.
Mittal S; Song X; Vig BS; Amidon GL
Pharm Res; 2007 Jul; 24(7):1290-8. PubMed ID: 17377743
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity and effect on collagen biosynthesis of proline analogue of melphalan as a prolidase-convertible prodrug in cultured human skin fibroblasts.
Chrzanowski K; Bielawska A; Bielawski K; Wołczyński S; Pałka J
Farmaco; 2001 Sep; 56(9):701-6. PubMed ID: 11680815
[TBL] [Abstract][Full Text] [Related]
5. Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells.
Chrzanowski K; Bielawska A; Pałka J
Farmaco; 2003 Nov; 58(11):1113-9. PubMed ID: 14572862
[TBL] [Abstract][Full Text] [Related]
6. Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells.
Chrzanowski K; Pałka J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():209-11. PubMed ID: 11820612
[TBL] [Abstract][Full Text] [Related]
7. Prolidase as a prodrug converting enzyme I. Synthesis of proline analogue of chlorambucil and its susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1997; 42(1):148-55. PubMed ID: 9581474
[TBL] [Abstract][Full Text] [Related]
8. Proline-linked nitrosoureas as prolidase-convertible prodrugs in human breast cancer cells.
Bielawski K; Bielawska A; Słodownik T; Bołkun-Skórnicka U; Muszyńska A
Pharmacol Rep; 2008; 60(2):171-82. PubMed ID: 18443378
[TBL] [Abstract][Full Text] [Related]
9. Decreased cytotoxicity and increased antimitotic activity of proline analogue of chlorambucil as a prodrug in breast cancer MCF-7 cells.
Bielawska A; Chrzanowski K; Bielawski K; Pałka J
Acta Pol Pharm; 2000 Nov; 57 Suppl():103-5. PubMed ID: 11293233
[No Abstract] [Full Text] [Related]
10. Small-molecule based delivery systems for alkylating antineoplastic compounds.
Bielawski K; Bielawska A
ChemMedChem; 2008 Apr; 3(4):536-42. PubMed ID: 18157855
[TBL] [Abstract][Full Text] [Related]
11. Prolidase as a prodrug converting enzyme. III. Synthesis of proline analogues of melphalan and theirs susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1999; 44():190-9. PubMed ID: 10697434
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity activity of L-proline analogues of anthraquinone-2-carboxylic acid in breast cancer MCF-7 cells.
Bielawska A; Bielawski K; Pałka J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():207-8. PubMed ID: 11820611
[TBL] [Abstract][Full Text] [Related]
13. Prolidase as a prodrug converting enzyme. II. Synthesis of proline analogue of anthraquinone-2-carboxylic acid and its susceptibility to the action of prolidase.
Bielawska A; Bielawski K; Pałka J
Rocz Akad Med Bialymst; 1998; 43():201-9. PubMed ID: 9972056
[TBL] [Abstract][Full Text] [Related]
14. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Prolidase Induces Autophagic Death in MCF-7 Breast Cancer Cells.
Zareba I; Huynh TYL; Kazberuk A; Teul J; Klupczynska A; Matysiak J; Surazynski A; Palka J
Cell Physiol Biochem; 2020 Sep; 54(5):875-887. PubMed ID: 32918543
[TBL] [Abstract][Full Text] [Related]
16. Acetylsalicylic acid as a potential regulator of prolidase-convertible pro-drugs in control and neoplastic cells.
Chrzanowski K; Bielawska A; Bielawski K; Pałka J; Wołczyński S
Farmaco; 2004 Sep; 59(9):679-84. PubMed ID: 15337432
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-dependent regulation of prolidase activity in breast cancer MCF-7 cells.
Miltyk W; Anchim T; Wolczynski S; Palka J
Gynecol Endocrinol; 1999 Jun; 13(3):166-74. PubMed ID: 10451808
[TBL] [Abstract][Full Text] [Related]
18. Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells.
Wu Z; Shah A; Patel N; Yuan X
Bioorg Med Chem Lett; 2010 Sep; 20(17):5108-12. PubMed ID: 20674353
[TBL] [Abstract][Full Text] [Related]
19. Amidine analogue of chlorambucil is a stronger inhibitor of protein and DNA synthesis in breast cancer MCF-7 cells than is the parent drug.
Sienkiewicz P; Bielawski K; Bielawska A; Pałka J
Eur J Pharmacol; 2004 May; 492(2-3):95-101. PubMed ID: 15178351
[TBL] [Abstract][Full Text] [Related]
20. Prolidase in human breast cancer MCF-7 cells.
Palka JA; Phang JM
Cancer Lett; 1998 May; 127(1-2):63-70. PubMed ID: 9619859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]